Executives
-
Galvin RoyPresident, Global Plasma & BC -
Miller Laurie A.SVP, Human Resources
-
Simon, ChristopherPresident & CEO
-
Strong Stewart WPresident, Global Hospital
-
Lingamneni AnilaEVP, Chief Technology Officer
-
Llorens JosepEVP, Global Manufacturing
-
Basil Michelle LEVP and General Counsel
-
Maunsell Farris MaryanneVP, Chief Accounting Officer
-
Darecca JamesEVP, Chief Financial Officer
?
Galvin Roy
President, Global Plasma & BC
Haemonetics Corporation
US, Boston [HQ]
CIK
1950021
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
4,538
Price per Share :
$73.49
Equivalence :
$333,497.62
Transaction History
-
F4,538 Shares After TransactionValue : $437,871.62$20,648.86Transaction Date : 05/15/24
-
Footnotes
-
-
Footnotes:#1 Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.#2 This number includes unvested RSUs previously reported as well as 157 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024.
-
A7,410 Shares After TransactionValue : $n/a$0.0Transaction Date : 05/17/24
-
Footnotes
-
-
Footnotes:#1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.#2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.#3 This number includes unvested RSUs previously reported.
-
F4,595 Shares After TransactionValue : $396,962.05$13,822.40Transaction Date : 11/01/23
-
Footnotes
-
-
Footnotes:#1 Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.#2 This number includes unvested RSUs previously reported as well as 66 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2023.
-
F7,373 Shares After TransactionValue : $527,022.04$11,508.28Transaction Date : 11/01/24
-
Footnotes
-
-
Footnotes:#1 Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.#2 This number includes unvested RSUs previously reported as well as 124 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2024.